Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
US Adults
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Cause-specific Mortality
100%
Bilirubin Level
100%
Total Bilirubin Level
100%
Low Risk
50%
All-cause Mortality
37%
Hazard Ratio
25%
Cancer Mortality
25%
Total Bilirubin
25%
95% Confidence Interval
25%
Progressive Disease
12%
National Health Interview Survey
12%
Cardiovascular Mortality
12%
NHANES
12%
Disease Severity
12%
Multivariable Model
12%
Metabolic Syndrome Prevalence
12%
Bilirubin
12%
Chronic Progressive
12%
End-stage Liver Disease
12%
Cox Regression Model
12%
Disease Status
12%
Protective Association
12%
Steatosis
12%
American Adults
12%
Disease Spectrum
12%
National Representative Sample
12%
Medicine and Dentistry
Bilirubin
100%
Nonalcoholic Fatty Liver
100%
Specific Mortality
100%
All Cause Mortality
27%
Hazard Ratio
18%
Malignant Neoplasm
9%
Prevalence
9%
Disease Severity
9%
Metabolic Syndrome
9%
Steatosis
9%
End Stage Liver Disease
9%
Cardiovascular System Cancer
9%
Cardiovascular System
9%
National Health and Nutrition Examination Survey
9%
Diseases
9%
Cox Regression Model
9%
Median Follow Up
9%
Mathematics
Hazard Ratio
100%
Confidence Interval
100%
Median
50%
Proportional Hazards Model
50%
Disease Status
50%
Regression Model
50%
Representative Sample
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bilirubin
100%
Nonalcoholic Fatty Liver
100%
All Cause Mortality
27%
Malignant Neoplasm
9%
Prevalence
9%
Metabolic Syndrome X
9%
End Stage Liver Disease
9%
Steatosis
9%
Disease Severity
9%
Cardiovascular System Cancer
9%
Diseases
9%